Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127,566 | 133,517 | 176,765 | 253,029 | 124,806 |
| Marketable Securities | 28,763 | 75,510 | 253,298 | 297,967 | 253,458 |
| TOTAL | $160,808 | $213,515 | $444,437 | $558,101 | $384,467 |
| Non-Current Assets | |||||
| PPE Net | 77,308 | 70,689 | 66,917 | 65,464 | 46,775 |
| Investments And Advances | 0 | 0 | 10,051 | 195,881 | 33,731 |
| Intangibles | 199,822 | 199,822 | 199,822 | 199,822 | 199,822 |
| Other Non-Current Assets | 63,082 | 81,273 | 101,493 | 110,139 | 65,501 |
| TOTAL | $340,212 | $351,784 | $378,283 | $571,306 | $345,829 |
| Total Assets | $501,020 | $565,299 | $822,720 | $1,129,407 | $730,296 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,210 | 4,108 | 2,857 | 2,219 | 2,253 |
| Accrued Expenses | 27,689 | 47,184 | 40,909 | 31,475 | 25,486 |
| Other current liabilities | N/A | N/A | 55,345 | 56,382 | N/A |
| TOTAL | $45,433 | $64,487 | $111,504 | $99,235 | $31,451 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 205,083 | 213,306 | 211,901 | 301,670 | 1,120,029 |
| TOTAL | $205,083 | $213,306 | $211,901 | $301,670 | $1,120,029 |
| Total Liabilities | $250,516 | $277,793 | $323,405 | $400,905 | $1,151,480 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 225,025 | 220,448 | 191,361 | 189,543 | N/A |
| Common Shares | 22 | 20 | 19 | 18 | 2 |
| Retained earnings | -1,604,850 | -1,338,091 | -1,054,836 | -785,360 | -429,432 |
| Other shareholders' equity | 14 | -60 | -4,327 | -1,366 | 30 |
| TOTAL | $250,504 | $287,506 | $499,315 | $728,502 | $-421,184 |
| Total Liabilities And Equity | $501,020 | $565,299 | $822,720 | $1,129,407 | $730,296 |